MPAM
MEDP icon

Monarch Partners Asset Management’s Medpace MEDP Stock Holding History

Monarch Partners Asset Management’s Portfolio MEDP Stock Details MEDP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-13,689
Closed -$2.59M – 169
2021
Q3 		$2.59M Sell
13,689
-20,681
-60% -$3.77M 0.38% 96
2021
Q2 		$6.07M Buy
34,370
+30,390
+764% +$5.24M 0.87% 51
2021
Q1 		$653K Buy
+3,980
New +$609K 0.1% 147

Other funds holding MEDP

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
ESCM
Echo Street Capital Management New York $747M AUM 24.25% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $29.7B AUM 43.33% 1-Year Est. Return

Monarch Partners Asset Management's MEDP Position: Q4 2021 in Review

Monarch Partners Asset Management sold out of Medpace (MEDP) in Q4 2021, closing a stake of 13,689 shares — an estimated $2.59M sold.

Monarch Partners Asset Management first reported a position in MEDP in Q1 2021 and held it in 3 quarters. The position peaked at $6.07M in Q2 2021. 386 funds tracked by Wall St. Rank hold MEDP as of Q4 2021.

  • Monarch Partners Asset Management reported no remaining Medpace position as of Q4 2021 after selling out during the quarter.
  • Monarch Partners Asset Management sold 13,689 Medpace shares in Q4 2021, an estimated $2.59M.
  • Monarch Partners Asset Management first reported a position in Medpace in Q1 2021 and held it in 3 quarters.
  • Monarch Partners Asset Management's Medpace position peaked at $6.07M in Q2 2021.
  • 386 funds tracked by Wall St. Rank held Medpace as of Q4 2021.

Based on Monarch Partners Asset Management's 13F filing for Q4 2021, filed 3 Feb 2022.